TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $107,164,000 | -51.5% | 7,862,379 | -41.8% | 0.32% | -39.0% |
| Q3 2021 | $221,157,000 | -15.2% | 13,501,650 | -12.9% | 0.53% | +9.5% |
| Q2 2021 | $260,747,000 | -23.7% | 15,492,997 | -17.2% | 0.48% | -28.6% |
| Q1 2021 | $341,775,000 | +117.9% | 18,717,144 | +117.2% | 0.68% | +62.8% |
| Q4 2020 | $156,851,000 | +660.4% | 8,618,165 | +645.3% | 0.42% | +241.8% |
| Q3 2020 | $20,628,000 | – | 1,156,297 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |